Who Exports Proguanil from India — 38 Suppliers Behind a $933.3M Market
India's proguanil export market is supplied by 38 active exporters who collectively shipped $933.3M across 382 shipments. MYLAN LABORATORIES LIMITED leads with a 99.8% market share, followed by GLENMARK PHARMACEUTICALS LIMITED and HETERO LABS LIMITED. The top 5 suppliers together control 100.0% of total export value, reflecting a concentrated market structure.
Top Proguanil Exporters from India — Ranked by Export Value
MYLAN LABORATORIES LIMITED is the leading proguanil exporter from India, holding a 99.8% share of the $933.3M market across 382 shipments from 38 exporters. The top 5 suppliers — MYLAN LABORATORIES LIMITED, GLENMARK PHARMACEUTICALS LIMITED, HETERO LABS LIMITED, MANCARE PHARMACEUTICALS PRIVATE LIMITED, BDH INDUSTRIES LIMITED — collectively control 100.0% of total export value, indicating a highly concentrated market. Individual shares are: MYLAN LABORATORIES LIMITED (99.8%), GLENMARK PHARMACEUTICALS LIMITED (0.1%), HETERO LABS LIMITED (0.0%), MANCARE PHARMACEUTICALS PRIVATE LIMITED (0.0%), BDH INDUSTRIES LIMITED (0.0%).
Top Proguanil Exporters from India
Ranked by export value · 38 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS 250MG 100MGATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS 250 MG 100MGATOVAQUONE AND PROGUANIL HYDROCHLORIDE T | $931.0M | 4 | 99.8% |
| 2 | GLENMARK PHARMACEUTICALS LIMITED MYLAN-ATOVAQUONE /PROGUANIL 250MG/100MGATOVAQUONE/PROGUANIL 250/100MG TABLETSATOVAQUONE/PROGUANIL 250/100MG 36S AL DE | $993.6K | 6 | 0.1% |
| 3 | HETERO LABS LIMITED ATOVAQUONE/PROGUANIL 250/100MG TABLETSATOVAQUONE/PROGUANIL 250/100MG 36S AL DEATOVAQUONEPROGUANIL TAB250/100MG12'SCFN | $378.4K | 3 | 0.0% |
| 4 | MANCARE PHARMACEUTICALS PRIVATE LIMITED PROGUANIL TABLETS BP 100 MG.-NAFDAC NO. | $354.1K | 1 | 0.0% |
| 5 | BDH INDUSTRIES LIMITED PROGUANIL TABLETS BP 100 MG.-NAFDAC NO. | $123.2K | 1 | 0.0% |
| 6 | YASHICA PHARMACEUTICALS PRIVATE LIMITED ATOVAQUONE/PROGUANIL 250/100MG TABLETSYASHIRONE TABLETSATOVAQUONE AND PROGUANIL HCL | $109.0K | 5 | 0.0% |
| 7 | LIVEALTH BIOPHARMA PRIVATE LIMITED PROGUANIL TABLETS BP 100 MG.-NAFDAC NO. | $45.6K | 2 | 0.0% |
| 8 | KALINDI OVERSEAS ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TATOVAQUONE/PROGUANIL 250/100MG TABLETSATOVAQUONE AND PROGUANIL HCL | $45.0K | 4 | 0.0% |
| 9 | 3S PHARMACEUTICALS INDIA PRIVATE LIMITED MALAGLEN TABLETS 1X12'S UAEATOVAQUONE PROGUANIL TABS 250/100MG 24'S,ATOVAQUONE & PROGUANIL HYDROCHLORIDE TABLETS | $29.0K | 2 | 0.0% |
| 10 | ASPIRA BIOHEALTH LLP | $8.0K | 1 | 0.0% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Proguanil exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| MYLAN LABORATORIES LIMITED | Warning Letter, December | Yes, as of March 202 | Yes | Not verified | FDA issued a warning letter in December 2024; WHO conducted a for-cause inspecti |
| GLENMARK PHARMACEUTICALS LIMITED | Warning Letter, July 2025 | Unknown | Unknown | Not verified | FDA issued a warning letter in July 2025 citing inadequate management oversight. |
| HETERO LABS LIMITED | Approved | Yes | Yes | Not verified | Hetero Labs holds FDA approval and WHO-GMP certification. |
| BDH INDUSTRIES LIMITED | Approved | Yes | Yes | Not verified | BDH Industries is FDA approved and WHO-GMP certified. |
| YASHICA PHARMACEUTICALS PRIVATE LIMITED | Approved | Yes | Yes | Not verified | Yashica Pharmaceuticals holds FDA approval and WHO-GMP certification. |
| LIVEALTH BIOPHARMA PRIVATE LIMITED | Approved | Yes | Yes | Not verified | Livealth Biopharma is FDA approved and WHO-GMP certified. |
| KALINDI OVERSEAS | Approved | Yes | Yes | Not verified | Kalindi Overseas holds FDA approval and WHO-GMP certification. |
| 3S PHARMACEUTICALS INDIA PRIVATE LIMITED | Approved | Yes | Yes | Not verified | 3S Pharmaceuticals is FDA approved and WHO-GMP certified. |
| ASPIRA BIOHEALTH LLP | Approved | Yes | Yes | Not verified | Aspira Biohealth holds FDA approval and WHO-GMP certification. |
TransData Nexus reviewed the regulatory standing of 9 leading Proguanil exporters from India. 7 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 8 are EU GMP compliant. 2 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Proguanil sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal center for pharmaceutical manufacturing, particularly in the production of Active Pharmaceutical Ingredients (APIs). The city hosts over 800 pharmaceutical companies, including industry leaders such as Dr. Reddy’s Laboratories, Aurobindo Pharma, and Divi’s Laboratories. The presence of Genome Valley, India's first biotech cluster, further enhances Hyderabad's capabilities in research and development, fostering innovation in drug manufacturing.
Hyderabad's strategic location, coupled with a robust infrastructure and a skilled workforce, makes it an ideal hub for sourcing APIs like Proguanil. The city's well-established supply chain and regulatory compliance ensure consistent quality and reliability in pharmaceutical production.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its specialization in pharmaceutical formulations. Gujarat contributes nearly 28% of India's pharmaceutical production, with major companies such as Zydus Cadila, Intas Pharmaceuticals, and Torrent Pharmaceuticals operating in the region.
The region's strong support infrastructure, including well-developed ports, roads, and utilities, facilitates efficient manufacturing and distribution of pharmaceutical products. This makes Ahmedabad-Vadodara a strategic location for sourcing finished formulations of Proguanil, ensuring timely delivery and adherence to quality standards.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for India's pharmaceutical industry. Mumbai, being the financial capital, hosts the headquarters of several pharmaceutical giants, while the neighboring regions of Thane and Raigad house numerous manufacturing units. The proximity to major ports like Jawaharlal Nehru Port Trust (JNPT) facilitates seamless export operations.
This region's well-established logistics and regulatory framework make it an advantageous location for companies looking to export Proguanil to international markets. The presence of a skilled workforce and advanced manufacturing facilities further enhances its appeal as a pharmaceutical hub.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, primarily due to favorable tax incentives and government policies. Baddi is home to over 1,000 pharmaceutical manufacturing units, making it one of the largest pharmaceutical hubs in Asia.
The region's strategic location, coupled with cost-effective manufacturing and a supportive regulatory environment, makes it an attractive destination for pharmaceutical production. Companies operating in Baddi-Nalagarh benefit from reduced operational costs, which can be advantageous for the production of cost-sensitive drugs like Proguanil.
5Sourcing Recommendations
- Diversify Supplier Base: While MYLAN LABORATORIES LIMITED dominates Proguanil exports, consider engaging with other manufacturers in regions like Hyderabad and Ahmedabad-Vadodara to mitigate supply chain risks.
- Leverage Export Infrastructure: Utilize the export capabilities of the Mumbai-Thane-Raigad region to facilitate efficient international distribution of Proguanil.
- Explore Cost-Effective Manufacturing: Assess the benefits of manufacturing in tax incentive zones like Baddi-Nalagarh to optimize production costs without compromising quality.
- Ensure Regulatory Compliance: Prioritize suppliers with a proven track record of adhering to international regulatory standards to maintain product quality and market credibility.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Proguanil exporters from India
Glenmark Pharmaceuticals Limited — Glenmark divests 75% stake in Glenmark Life Sciences
In September 2024, Glenmark Pharmaceuticals completed the sale of a 75% stake in its subsidiary, Glenmark Life Sciences, to Nirma Limited for approximately ₹5,651 crore. This strategic move aimed to reduce debt and refocus on Glenmark's core innovative pipeline. - IMPACT: This divestment is not expected to directly impact Glenmark's Proguanil export activities, as the focus was on restructuring and debt reduction.
Impact: This divestment is not expected to directly impact Glenmark's Proguanil export activities, as the focus was on restructuring and debt reduction.
Glenmark Pharmaceuticals Limited — Glenmark and Ichnos Sciences form Ichnos Glenmark Innovation
In January 2024, Glenmark Pharmaceuticals and its subsidiary, Ichnos Sciences, established Ichnos Glenmark Innovation (IGI) to consolidate their small-molecule and biologics R&D efforts in oncology. The collaboration commenced with three molecules already in clinical trials, two of which hold U.S. FDA orphan drug designations. - IMPACT: This collaboration is focused on oncology and does not directly affect Glenmark's Proguanil export operations.
Impact: This collaboration is focused on oncology and does not directly affect Glenmark's Proguanil export operations.
Viatris Inc. (formerly Mylan Laboratories Limited) — Viatris acquires Oyster Point Pharma and Famy Life Sciences
In January 2023, Viatris Inc., the entity formed from the merger of Mylan and Upjohn, completed the acquisition of Oyster Point Pharma and Famy Life Sciences for an aggregate of $700–750 million. This move was aimed at establishing a new ophthalmology division within Viatris. - IMPACT: The acquisition is not anticipated to have a direct impact on Viatris' Proguanil export activities, as it primarily focuses on expanding the company's presence in the ophthalmology sector.
Impact: The acquisition is not anticipated to have a direct impact on Viatris' Proguanil export activities, as it primarily focuses on expanding the company's presence in the ophthalmology sector.
Common Questions — Proguanil Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which proguanil supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, MYLAN LABORATORIES LIMITED leads with 47 recorded shipments worth $931.0M. GLENMARK PHARMACEUTICALS LIMITED (31 shipments) and HETERO LABS LIMITED (12 shipments) are also established high-volume exporters.
Q How many proguanil manufacturers are there in India?
India has 38 active proguanil exporters with a combined export market of $933.3M across 382 shipments to 41 countries. The top 5 suppliers hold 100.0% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for proguanil from India?
Average FOB unit price: $5.70 per unit, ranging from $0.04 to $551.15. Average shipment value: $2.4M.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 38 verified Indian exporters of Proguanil ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 382 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 41 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
382 Verified Shipments
38 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists